2 With the identification of novel cAMP binding effecter molecules in Trypanosoma, 3 role of cAMP in kinetopalstida parasites gained an intriguing break through. Despite 4 earlier demonstrations of role of cAMP in survival of Leishmania during macrophage 5 infection, there is essential need to specifically clarify involvement of cAMP in 6 various cellular processes in the parasite. In this context, we sought to gain a 7 comprehensive understanding of the effect of cAMPanalogs and cAMP-8 phosphodiesterase (PDE) inhibitors on proliferation of log phase parasites. 9 Administration of both hydrolysable (8-pCPT-cAMP) and non-hydrolysable analogs 10 (Sp-8-pCPT-cAMPS) of cAMP resulted in significant decrease of Leishmania 11 proliferation. Amongst the various PDE inhibitors, etazolate was found to be potently 12 anti-proliferative. BrdU cell proliferation and K/N/F-enumeration microscopic study 13 revealed that both cAMP analogues and selective PDE inhibitors resulted in 14 significant cell cycle arrest at G 1 phase with reduced S-phase population. 15 Furthermore, careful examination of the flagellar motility patterns revealed 16 significantly reduced coordinated forward flagellar movement of the promastigotes 17 with a concomitant decrease in cellular ATP levels. Alongside, 8-pCPT-cAMP and 18
cell communications [7, 8] . Moreover, the isoform PDEC from T. cruzi was shown to 17 be involved in osmoregulation and the potential of it to be a drug target was validated 18 by high throughput screening of a series of PDE inhibitors [9] , which led to 19 identification of tetrahydrophthalazinone compound A (Cpd A) [7] . These 20 observations underpin the possibilities of cAMP pathway as a candidate target for 21 drug development [9] . 22 Leishmania differs in terms of its repertoire of cAMP-pathway components from T. 23 brucei as the number of AC genes is considerably less. Additionally it encodes one 24 cytosolic heme-containing AC which is absent in Trypansoma, indicating presence of 25 subcellular microdomain specific cAMP signalling in this parasite [10, 11] . Elevation 5 1 of cAMP was found to be a prerequisite for differentiation condition induced cell cycle 2 arrest (G1) and adaptation against oxidative stress encountered during early 3 macrophage invasion [12, 13] . Moreover, the crucial role played by both exogenous 4 and endogenous cAMP in chemotaxis by sensing chemical cues and inducing 5 flagellar wave reversal [14] suggest the existence of definitive cAMP regulated 6 mechanisms in the parasite. Similar to other kinetoplastida parasites, Leishmania 7 encodes at least 7 different cyclic nucleotide targeted phosphodiesterases (PDE). X-8 ray crystallography structure of L. major PDEB1 and B2 has been determined and 9 it's superposition with human PDEs revealed presence of a unique sub pocket 10 nearby inhibitor binding sites [15] , widening the scope of selective drug designing.
11
The differentially regulated L. donovani PDEA was characterized to be a high K M 12 cytosolic PDE that regulates cytosolic cAMP pool and modulate expression of anti- of the PDE inhibitors tested showed little effect on cell proliferation (Table 1) .
23
Since cAMP analogues and PDE inhibitors showed anti-proliferative effects on the Figure 1D ) showed 6 K/N/F profiles comparable to that of the untreated cells. Taken together, these 7 results suggest a probable G1 arrest of Leishmania promastigotes when they were 8 treated with cAMP analogues and PDE inhibitors. in G 1 , S and G 2 /M phase ( Figure 2A and Table S2 ). Treatment of the cells with 8-
12
pCPT-cAMP reduced the S phase fraction indicating a potent role of 8-pCPTcAMP 13 induced cell cycle arrest at G 1 phase, which also indicated by an increase in G1 14 population ( Figure 2B and Table S2 ). Similarly, Sp-8-pCPT-cAMPS reduced the 15 percentages of S phase cells significantly and increased G1 phase population 16 ( Figure 2C and analysed for cell cycle progression by propidium iodide staining based FACS analysis (Table S1 ).
7
Representative histograms from 24h data are presented. Figure 3B ). Since, one of the factors effecting flagellar motility is intracellular 8 ATP generation, we determined the cellular ATP levels by ATP bio-luminescent 9 assay after treating the parasites with cAMP analogues and PDE inhibitors. 
8
Since the ATP levels of cAMP analogue-treated and PDE inhibitor-treated parasites 9 were depleted, the impact of these on mitochondrial function was further elucidated 1 by scoring mitochondrial membrane using JC-1. 8-pCPTcAMP induced maximum 2 reduction in mitochondrial membrane potential compared to control cells reduction 3 (26.1% ± 1.9%) whereas Sp-8-pCPTcAMPS induced moderate effect (10.2% ± 0.9% 4 reduction) at 100 µM ( Figures 4A -4C weight (in grams). A dose-related inhibition was noted at a dose of 5 mg/kg/day and 1 10 mg/kg/day with great reduction of liver and spleen parasite burden by 70.7 % ± 2 6.9% and 79.5 % ± 7.2% compared to untreated infected mice ( Figures 5C and 5D ). the drug at a dose of 10 mg/kg for 15 days [30, 31] . In coherence to these reports 8 and based on our in vitro cytotoxicity analysis on RAW264.7 cell line in mice, we 9 tested dose range between 5 to 20 mg/kg which appeared to be well tolerated by the 10 mice. With its potential inhibitory impact on amastigote proliferation in vitro and in The entire study was in strict accordance with the recommendations in the Guide for The principle underlying the MTT assay is that living mitochondria convert MTT to a 2 dark blue compound, formazan, which is soluble in acid isopropyl alcohol. Formazan 3 was detected at 570 nm on the microplate reader. The percentage viability was 4 obtained by calculating the ratio of OD values in wells with treated cells versus the 5 wells with controls multiplied by 100. Table-S1. Cell cycle progression after cAMP-analogue treatment. G1 synchronized L.
8 donovani promastigotes were exposed to various doses of cAMP analogues. Cell cycle 9 stage specific distribution of the populations were analyzed by propidium iodide nuclear 10 staining based FACS analysis after various time periods.
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